deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT00826202

D-serine for the Schizophrenia Prodrome

D-Serine vs Placebo for the Schizophrenia Prodrome

Sponsor: Nathan Kline Institute for Psychiatric Research

Conditions Schizophrenia Prodrome
Interventions D-serine Placebo
Updated 8 times since 2017 Last updated: Jul 7, 2017 Started: Mar 31, 2009 Primary completion: Nov 30, 2012 Completion: Nov 30, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00826202, this PHASE2 trial focuses on Schizophrenia Prodrome and remains completed. Sponsored by Nathan Kline Institute for Psychiatric Research, it has been updated 8 times since 2009, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  2. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

    Status: Unknown Status → Completed

  3. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE2

    First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Nathan Kline Institute for Psychiatric Research
  • National Institute of Mental Health (NIMH)
  • The Zucker Hillside Hospital
  • Yale University
Data source: Nathan Kline Institute for Psychiatric Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations